News

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
According to KFF, the new executive order directs the Department of Health and Human Services to work with Congress to ...
A De Pere woman who allegedly tried to get rid of illegal drugs during a Fond du Lac County traffic stop on I-41 was arrested ...
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...
The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products ...
President Trump directed his administration to help states import drugs from Canada. But a proposal to alter a Medicare ...
A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...
A daily pill from Eli Lilly lowered blood sugar levels and induced weight loss in people with Type 2 diabetes, the company ...
Even the solid proposals set out by the Trump administration are being undermined by its actions taken elsewhere.
Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...